Autistic Disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
Further studies of mouse KO models of ASD genes such as Sema 3F or NRP2 may be informative to clinical phenotypes contributing to the pathogenesis in autism and epilepsy patients.
|
30635860 |
2019 |
Autistic Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The NRP2 G allele conferred a 2.29-fold increased risk to autism relative to the T allele (OR = 2.29, 95%CI = 1.23-4.29, P = 0.009).
|
28484884 |
2017 |
Autistic Disorder
|
0.330 |
GeneticVariation
|
disease |
LHGDN |
We found significant genetic association between autism and two of the SNPs of the NRP2 gene (rs849578: P = 0.017, rs849563: P = 0.027), as well as specific haplotypes, especially those formed by rs849563.
|
17427189 |
2007 |
Autistic Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
We found significant genetic association between autism and two of the SNPs of the NRP2 gene (rs849578: P = 0.017, rs849563: P = 0.027), as well as specific haplotypes, especially those formed by rs849563.
|
17427189 |
2007 |
Autistic Disorder
|
0.330 |
Biomarker
|
disease |
CTD_human |
We found significant genetic association between autism and two of the SNPs of the NRP2 gene (rs849578: P = 0.017, rs849563: P = 0.027), as well as specific haplotypes, especially those formed by rs849563.
|
17427189 |
2007 |
Jacksonian Seizure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Seizures
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
NPN2 deficient mice had shorter seizure latencies, increased vulnerability to seizure-related death, were more likely to develop spontaneous recurrent seizure activity after chemical challenge, and had an increased slope on input/output curves.
|
18657176 |
2009 |
Complex partial seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Generalized seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Clonic Seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Visual seizure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Tonic Seizures
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Epileptic drop attack
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Seizures, Somatosensory
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Seizures, Auditory
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Olfactory seizure
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Gustatory seizure
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Vertiginous seizure
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Tonic - clonic seizures
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Non-epileptic convulsion
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Single Seizure
|
0.300 |
Biomarker
|
disease |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Atonic Absence Seizures
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Convulsive Seizures
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Seizures, Focal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |
Seizures, Sensory
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Decreased number of interneurons and increased seizures in neuropilin 2 deficient mice: implications for autism and epilepsy.
|
18657176 |
2009 |